Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: An in silico approach

Virology Journal

Volumn 8, Issue , 2011, Pages

  Shehzadi, Abida ^a   Ur Rehman, Shahid ^a   Idrees, Muhammad ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; ISOLEUCINE; LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHIONINE; PHENYLALANINE; TYROSINE; VALINE; VIRUS PROTEIN; PROTEOME;

ALLELE; ARTICLE; COMPUTER MODEL; CYTOTOXIC T LYMPHOCYTE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PAKISTAN; PREDICTION; PROTEOMICS; VACCINATION; BIOLOGY; GENETICS; HEPATITIS C; IMMUNOLOGY; NUCLEOTIDE SEQUENCE; VIROLOGY;

HEPATITIS C VIRUS; RNA VIRUSES;

COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; EPITOPES, T-LYMPHOCYTE; HEPACIVIRUS; HEPATITIS C; HUMANS; PAKISTAN; PROTEOME; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79551688644     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-55     Document Type: Article

References (33)

1. Biological characteristics of dengue virus and potential targets for drug design. R Qi L Zhang C Chi, Acta Biochim Biophys Sin 2008 40 91 (Pubitemid 351300899)
2. Serologic Evidence of West Nile Virus Infection in Horses, Coahuila State, Mexico. JB Blitvich I Fernandez-Salas FJ Contreras-Cordero LN Marlenee IJ Gonzalez-Rojas N Komar JD Gubler HC Calisher JB Beaty, Emerging Infectious Diseases 2003 9 7 853 856 12890327 (Pubitemid 36801587)
3. Introduction to classical swine fever: virus, disease and control policy. V Moennig, Veterinary Microbiology 2000 73 93 102 10.1016/S0378-1135(00)00137-1 10785320 (Pubitemid 30227285)
4. Focal Distribution of Hepatitis C Virus RNA in Infected Livers. DJ Stiffler M Nguyen AJ Sohn C Liu D Kaplan C Seeger, PLoS ONE 2009 4 8 1 7 10.1371/journal.pone.0006661
5. Epidemiology of hepatitis C virus infection in Pakistan. SN Raja AK Janjua, J Microbiol Immunol Infect 2008 41 4 8 18327420
6. Hepatitis C virus infection: An enigma continues. SN Raja NN Singh AK Janjua R Najam-Ul-Haq, Medicine Today 2006 4 3 93 101
7. Geographical distribution of hepatitis C virus genotype in India. RB Das B Kundu R Khandapkar S Sahni, Indian J Pathol Microbiol 2002 45 3 323 328 12785176
8. Hepatitis C- new developments in the studies of the viral life cycle. M Rychowska K Biekowska-Szewczyk, Acta Biochimica Polonica 2007 54 4 703 715 17957276
9. Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Modou Jobarteh Marine Malfroy Ingrid Peterson Adam Jeng Sarge-Njie Ramu Abraham Alabi Kevin Peterson Matt Cotten Andrew Hall Rowland-Jones Sarah Hilton Whittle Richard Tedder Assan Jaye Maimuna Mendy, Virology Journal 2010 7 230 239 10.1186/1743-422X-7-230 20843322
10. Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. DV Re L Caggiari DS Vita C Mazzaro M Lenzi M Galli G Monti C Ferri LA Zignego A Gabrielli D Sansonno F Dammacco M Libra N Sacchi R Talamini M Spina R Cannizzaro M Guidoboni R Dolcetti, Digestive and Liver Disease 2007 39 1 65 71
11. Effect of vitamin "e" supplements in herapy of chronic hepatitis c: a histological study. I Wazir F Wazir M Javed M Saeed Khan H Najeeb-ul-Haq, Gomal Journal of Medical Sciences 2008 6 2 81 86
12. Antiviral action of interferon- against hepatitis C virus replicon and its modification by interferon- and interleukin-8. Y Jia L Wei D Jiang J Wang X Cong R Fei, J Gastroenterology and Hepatology 2007 22 1278 1285 10.1111/j.1440-1746.2007.04957.x (Pubitemid 47222665)
13. Hepatitis C Virus (HCV) Infection and Hepatic Steatosis. JE Yoon K Hu, Int J Med Sci 2006 3 2 53 56 16614743
14. Hepatic Steatosis in Iranian Patients with Chronic Hepatitis C. M Minakari KF Sameni MH Shalmani M Molaee M Zali, Med Princ Pract 2008 17 126 130 10.1159/000112966 18287796 (Pubitemid 351301298)
15. Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection. A Zubair S Jamal A Mubarik, The Saudi Journal of Gastroenterology 2009 15 1 11 4 10.4103/1319-3767.45047
16. Prevalence of active hepatitis c virus infection in district mansehra Pakistan. Amjad Ali Ahmad Habib Ijaz Ali Khan Sheema Zaidi Gulshan Idrees Muhammad, Virology Journal 2010 7 334 338 10.1186/1743-422X-7-334 21092143
17. Distribution of hepatitis C virus genotypes in the Middle East. S Ramia J Eid-Fares, International Journal of Infectious Diseases 2006 10 272 277 10.1016/j.ijid.2005.07.008 16564719 (Pubitemid 43870211)
18. Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan. Amjad Ali Ahmed Habib Idrees Muhammad, Virology Journal 2010 7 203 209 10.1186/1743-422X-7-203 20796270
19. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. M Idrees S Riazuddin, BMC Infectious Diseases 2008 8 69 1 9 69 18171470
20. Hepatitis C V Irus Infection. G Lauer B Walker, N Engl J Med 2001 345 1 41 52 10.1056/NEJM200107053450107 11439948
21. Treatment and Vaccination for Hepatitis C: Present and Future. A Jawaid KA Khuwaja, J Ayub Med Coll 2008 20 1 129 133 Abbottabad
22. Combined antiviral activity of interferon- and RNA interference directed against epatitis without affecting vector delivery and gene silencing. Q Pan DS Henry JH Metselaar B Scholte J Kwekkeboom WH Tilanus ALH Janssen WJL Laan, J Mol Med 2009 87 713 722 10.1007/s00109-009-0470-3 19404587
23. Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIVq. J Gozlan K Lacombe E Gault G Raguin P Girard, Journal of Hepatology 2009 50 432 434 10.1016/j.jhep.2008.05.029 19070927
24. Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes. Lei Tan Huijun Lu Zhang Dan Tian Mingyao Bo Hu Zhuoyue Wang Ningyi Jin, Virology Journal 2010 7 363 376 10.1186/1743-422X-7-363 21134292
25. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands. AP Reche LE Reinherz, Nucleic Acids Research 2005 33 138 142 10.1093/nar/gki357 (Pubitemid 44529896)
26. MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. LG Zhang MA Khan NK Srinivasan TJ August V Brusic, Nucleic Acids Research 2005 33 172 179 10.1093/nar/gki452 (Pubitemid 44529903)
27. T cell vaccines for microbial infections. LH Robinson RR Amara, Nature Medicine Suppliment 2005 11 4 25 32 10.1038/nm1212
28. Immuno-informatics: Mining genomes for vaccine components. DSA Groot H Sbai SC Aubin J Mcmurry W Martin, Immunology and Cell Biology 2002 80 255 269 10.1046/j.1440-1711.2002.01092.x 12067413 (Pubitemid 34639376)
29. Definition of supertypes for HLA molecules using clustering of specificity matrices. O Lund M Nielsen C Kesmir GA Petersen C Lundegaard P Worning C Sylvester-Hvid K Lamberth G Røder S Justesen S Buus S Brunak, Immunogenetics 2004 55 12 797 810 10.1007/s00251-004-0647-4 14963618 (Pubitemid 38650985)
30. ProPred1: prediction of promiscuous MHC Class-I binding sites. H Singh SPG Raghava, Bioinformatics 2003 19 8 1009 1014 10.1093/bioinformatics/btg108 12761064 (Pubitemid 36675822)
31. In Silico Prediction of Epitopes in Virulence Proteins of Mycobacterium Tuberculosis H37Rv for Diagnostic and Subunit Vaccine Design. P Somvanshi V Singh KP Seth, Journal of Proteomics & Bioinformatics 2008 1 3 143 153
32. A simple method for displaying the hydropathic character of a protein. J Kyte FR Doolittle, Journal of Molecular Biology 1982 157 1 105 132 10.1016/0022-2836(82)90515-0 7108955
33. A systematic bioinformatics approach for selection of epitope-based vaccine targets. MA Khan O Miotto TA Heiny J Salmon NK Srinivasan MJE Nascimento JETA Marques V Brusic WT Tan TJ August, Cellular Immunology 2006 244 141 147 10.1016/j.cellimm.2007.02.005 17434154 (Pubitemid 46733910)